Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
collagen type IX alpha 2 chain | 0.572 | 0.769 | 1.0E-08 |
|
disease | 0.400 | moderate | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
small nuclear ribonucleoprotein polypeptides B and B1 | 0.595 | 0.731 | 0.71 |
|
disease | 0.400 | strong | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
calcium/calmodulin dependent serine protein kinase | 0.538 | 0.808 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 1998 | 1998 | ||||||||
|
atrophin 1 | 0.409 | 0.885 | 1.00 |
|
disease | 0.400 | strong | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
fibroblast growth factor 9 | 0.528 | 0.846 | 0.95 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
fibroblast growth factor receptor 3 | 0.391 | 0.846 | 1.6E-05 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 2 | 0.572 | 0.731 | 0.31 |
|
disease | 0.400 | strong | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
TDP-glucose 4,6-dehydratase | 0.644 | 0.538 | 2.5E-09 |
|
disease | 0.400 | strong | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
fibroblast growth factor 8 | 0.507 | 0.769 | 0.68 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
TSR2 ribosome maturation factor | 0.743 | 0.500 | 0.80 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
collagen type IX alpha 3 chain | 0.569 | 0.769 | 3.3E-12 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
ribosomal protein L11 | 0.650 | 0.577 | 0.96 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
ribosomal protein S28 | 0.716 | 0.423 | 0.68 |
|
disease | 0.400 | moderate | 0 | 0 | |||||||||||
|
selenoprotein I | 0.769 | 0.385 | 0.64 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
G protein subunit alpha i3 | 0.653 | 0.615 | 3.8E-02 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
APC membrane recruitment protein 1 | 0.570 | 0.654 | 0.85 |
|
disease | 0.400 | strong | 0 | 0 | |||||||||||
|
endothelin receptor type A | 0.426 | 0.885 | 0.99 |
|
disease | 0.400 | strong | 0 | 0 | |||||||||||
|
phospholipase C beta 4 | 0.610 | 0.731 | 3.0E-06 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
transmembrane and coiled-coil domains 1 | 0.588 | 0.654 | 9.4E-10 |
|
disease | 0.400 | strong | 0 | 0 | |||||||||||
|
transforming growth factor beta 3 | 0.498 | 0.808 | 0.99 |
|
disease | 0.390 | None | 1.000 | 11 | 0 | 1995 | 2020 | ||||||||
|
bone morphogenetic protein 2 | 0.432 | 0.846 | 0.99 |
|
disease | 0.330 | strong | 1.000 | 4 | 0 | 2002 | 2017 | ||||||||
|
small ubiquitin like modifier 1 | 0.533 | 0.731 | 0.86 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 2006 | 2011 | ||||||||
|
fibroblast growth factor 10 | 0.530 | 0.692 | 0.94 |
|
disease | 0.320 | None | 0.667 | 3 | 0 | 2005 | 2013 | ||||||||
|
receptor like tyrosine kinase | 0.705 | 0.423 | 0.99 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2000 | 2006 | ||||||||
|
thymidylate synthetase | 0.425 | 0.846 | 0.72 |
|
disease | 0.310 | None | 1.000 | 2 | 0 | 2011 | 2013 |